Agilent Q1 Revenues up 2 Percent on Growth in Life Sciences and Addition of Dako | GenomeWeb

NEW YORK (GenomeWeb News) – Agilent Technologies reported after the close of the market on Thursday a 2 percent bump in revenues during its fiscal first quarter but missed analyst estimates on the top and bottom lines.

Total revenues for the three months ended Jan. 31 came in at $1.68 billion, up from $1.64 billion during the first quarter of Fiscal Year 2012, but just short of the average analyst estimate of $1.69 billion.

Orders in the quarter reached $1.71 billion, a 6 percent increase from $1.62 billion a year ago.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.